Search results
Results from the WOW.Com Content Network
Whooping cough (/ ˈ h uː p ɪ ŋ / or / ˈ w uː p ɪ ŋ /), also known as pertussis or the 100-day cough, is a highly contagious, vaccine-preventable bacterial disease. [1] [10] Initial symptoms are usually similar to those of the common cold with a runny nose, fever, and mild cough, but these are followed by two or three months of severe coughing fits. [1]
Pertussis vaccine is a vaccine that protects against whooping cough (pertussis). [ 1 ] [ 2 ] There are two main types: whole-cell vaccines and acellular vaccines. [ 1 ] [ 2 ] The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Human infectious diseases may be characterized by their case fatality rate (CFR), the proportion of people diagnosed with a disease who die from it (cf. mortality rate).It should not be confused with the infection fatality rate (IFR), the estimated proportion of people infected by a disease-causing agent, including asymptomatic and undiagnosed infections, who die from the disease.
Deaths from whooping cough (1 P) Pages in category "Whooping cough" ... Pertussis toxin; Pertussis vaccine This page was ...
Bordetella pertussis is a Gram-negative, aerobic, pathogenic, encapsulated coccobacillus bacterium of the genus Bordetella, and the causative agent of pertussis or whooping cough. Its virulence factors include pertussis toxin , adenylate cyclase toxin , filamentous haemagglutinin , pertactin , fimbria , and tracheal cytotoxin .
Health officials say the rise is due to pandemic-era health precautions wearing off alongside vaccine and booster hesitancy. Whooping cough cases are rising fast, with 4 times as many reports this ...
GSK's RSV, Shingles vaccines show on-par immune response in joint trial. ... RSV causes over 177,000 hospitalizations and 14,000 deaths in the United States annually, while over 1 million people ...
In a 1974 report ascribing 36 reactions to whooping cough (pertussis) vaccine, a prominent public-health academic claimed that the vaccine was only marginally effective and questioned whether its benefits outweigh its risks, and extended television and press coverage caused a scare. Vaccine uptake in the UK decreased from 81% to 31%, and ...